Single arm clinical study of Lenvatinib combined with Camrelizumab as the first-line treatment of advanced hepatocellular carcinoma
Latest Information Update: 01 Dec 2020
At a glance
- Drugs Camrelizumab (Primary) ; Lenvatinib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 01 Dec 2020 New trial record